期刊文献+

血浆淋巴细胞置换术联合VAD方案化疗治疗多发性骨髓瘤的临床观察 被引量:2

Clinical observation of the plasma exchange and lymphocyte apheresis with VAD regimen chemotherapy in multiple myeloma
下载PDF
导出
摘要 目的 研究血浆淋巴细胞置换术联合VAD方案化疗对多发性骨髓瘤患者的治疗效果.方法 多发性骨髓瘤患者每周行1~2次血浆淋巴细胞置换术,1~3次为一个疗程,随后采用VAD方案化疗.结果 患者红细胞沉降率(ESR)和球蛋白(GLB)分别下降45.1±15.3 mm/h 和 17.2±7.3 g/L,患者卡氏评分(KPS)有不同程度改善.结论 血浆淋巴细胞置换术能迅速改善多发性骨髓瘤患者的临床症状,提高VAD方案化疗疗效. Objective To study of the plasma exchange and lymphocyte apheresis with VAD regimen chemotherapy to multiple myeloma.Methord Plasma exchange and lymphocyte apheresis every week for one to three times,fllowed by VAD regimen chemotherapy to multiple myeloma.Result The value of ESR and GLB declined 45.1±15.3mm/h and 17.2±7.3g/L respectively.The KPS score of the patients improved.Conclusion This methord can relief the clinical symptoms rapidly and improve effective of the chemotherapy.
出处 《临床和实验医学杂志》 2006年第9期1269-,1271,共2页 Journal of Clinical and Experimental Medicine
关键词 多发性骨髓瘤 血浆置换术 淋巴细胞单采术 化疗 Multiple myeloma Plasma exchange lymphocyte apheresis Chemotherapy
  • 相关文献

参考文献4

  • 1[1]Guido T.Multiple myeloma and other plasma cell disorders.Hoffman R.Hematology-basic principles and practice.4th ed.Elsevier,2005:1501-1505.
  • 2[3]Reece DE.An update of the management of multiple myeloma:the changing landscape[J].Hematology Am Soc Hematol Educ Program,2005:353-359.
  • 3[4]Badros A,Barlogie B,Siegel E,et al.Improved outcome of allogeneic transplation in high-risk multiple myeloma patients after nonmyeloablative conditioning[J].J Clin Oncol,2002,20(5):1295-1303.
  • 4[5]Richardson PG,Barlogie B,Berenson J,et al.A phase 2 study of bortezomib in relapsed,refractory myeloma[J].N Engl J Med,2003,348(26):2609-2617.

同被引文献13

  • 1Hashimoto T. Hyperviscosity syndrome[J]. Nippon Rinsho, 1995, 53(3) :695-698.
  • 2Zarkovic M, Kwaan HC. Correction of hyperviscosity by apheresis [ J ]. Semin Thromb Hemost, 2003,29 ( 5 ) :535-542.
  • 3Mcleod BC. Therapeutic apheresis use of human serum albumin, fresh frozen plasma and cryosupematant plasma in therapeutic plas- ma exchange[ J]. Best Pract Res Clin Haematol, 2006,19 ( 1 ) : 157-167.
  • 4Ohara T, Oteki T, Suzuki T, et al. Efficacy of double fihration plasmapheresis with pegylated interferon/ribavirin therapy for intrac- table chronic hepatitis C patients and hepatitis C patients with com- bined liver cirrhosis by HBV, leading to early viral elimination[J]. Hepatogastroenterology, 2011,58 ( 105 ) : 133-136.
  • 5Lew WI-I, Chang C J, Lin JD, et al. Successful preoperative treat- ment of a Grave' s disease patient with agranulocytosis and hemoph- agocytosis using double filtration plasmapheresis[ J]. J Clin Apher, 2011,26(3) :159-161.
  • 6Rockx MA, Clark WF. Plasma exchange for treating cryoglobuline- mia: a descriptive analysis[ J]. Transfus Apher Sci, 2010,42(5) : 247 -251.
  • 7Fukatsu A, Tanaka Y, Iehara N. Double filtration plasmapheresis for therapy of hyperlipidemia[ J ]. Nippon Rinsho, 2004,62 ( Suppl 5 ) :595-598.
  • 8张之南,沈悌.血液病诊断与疗效标准[M].2版.北京:科学出版社,1998.34.
  • 9李永新,尹青松.双重膜过滤血浆置换治疗多发性骨髓瘤伴高球蛋白血症的临床观察[J].山东医药,2012,52(17):22-24. 被引量:1
  • 10多发性骨髓瘤肾损伤诊治专家共识[J].中华内科杂志,2017,56(11):871-875. 被引量:33

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部